Vimarsana
Biggest News Aggregation in the World

Page 47 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Topline Today - Breaking & Trending Today

Novan : Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum (Form 8-K) - Vimarsana News

Novan : Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum (Form 8-K)

Novan Reports Positive Topline Results from Pivotal Phase 3 Trial of SB206 in Patients with Molluscum Contagiosum - B-SIMPLE4 achieves statistical significance... | June 11, 2021

Protalix, Chiesi Global Announce Topline Results From The Interim Analysis Of Balance Study - Vimarsana News

Protalix, Chiesi Global Announce Topline Results From The Interim Analysis Of Balance Study

WASHINGTON (dpa-AFX) - Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., reported positive initial top line results from the Phase 3 study

14 Dead After Cable Car Plunges to Ground in Italy (VIDEO) - Vimarsana News

14 Dead After Cable Car Plunges to Ground in Italy (VIDEO)

The Italian government announced an investigation, which is likely to renew questions about the quality of Italy's transport infrastructure.

Source: newsy.com
Tessa Therapeutics Ltd: Tessa Therapeutics Announces Positive, Topline Data from Ongoing Phase 1 Trial of Allogeneic, Off-the-Shelf Cell Therapy, in Patients with Relapsed or Refractory CD30-Positive Lymphoma - Vimarsana News

Tessa Therapeutics Ltd: Tessa Therapeutics Announces Positive, Topline Data from Ongoing Phase 1 Trial of Allogeneic, Off-the-Shelf Cell Therapy, in Patients with Relapsed or Refractory CD30-Positive Lymphoma

(0) Data to be Presented Today at the ASGCT 24th Annual Meeting Demonstrated No Dose-Limiting Toxicity with Encouraging Clinical Activity in First 5 Patients Treated; Final Data Readout Expected by End of 2021 BEDMINSTER, N.J. and SINGAPORE, May 14, 2021) testing TT11X in patients with CD30+ lymphomas. The results will be presented today at the 24 th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT 2021). The presentation at ASGCT 2021 will highlight data from six patients treated with the therapy. The results demonstrated a favorable safety profile with encouraging clinical...

Detailed text transcripts for TV channel - CNN - 20180808:09:35:00 - Vimarsana News

Detailed text transcripts for TV channel - CNN - 20180808:09:35:00

Play. most race raters had that a solid republican. and the fact that the democrats have more votes right now than the republicans indicates that that district may be in play in the fall. >> let's talk about kansas. >> kris kobach, obviously, we all know this story, right? he was endorsed by donald trump. trump decided to go against the incumbent governor. and right now, that race is so close to call. we're waiting on johnson county. colyer is doing well in johnson county, but kobach is holding on to this tight lead. >> 500 votes. >> 500 votes. that's basically where it's been, 500, 800, all e...